8-K: Agilon Health Appoints Jeff Schwaneke as New Chief Financial Officer

Agilon Health has appointed Jeff Schwaneke as its new Chief Financial Officer, effective July 1, 2024, succeeding Timothy Bensley who is retiring.

Summary

• Agilon Health has appointed Jeff Schwaneke as its new Chief Financial Officer and Executive Vice President, effective July 1, 2024.
• Mr. Schwaneke will be resigning from the agilon health Board of Directors in connection with his appointment.
• He brings over 27 years of finance and operational experience, including 15 years in managed care.
• Mr. Schwaneke previously served as Executive Vice President at Centene Corporation, and also as their Chief Financial Officer and Treasurer from 2016 to 2021.
• His compensation includes a $625,000 annual base salary, a 75% target bonus, and various equity awards.
• He will receive a one-time sign-on bonus of $300,000.
• The company issued a press release on June 5, 2024, announcing the appointment.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the appointment of an experienced CFO and the company's optimistic outlook. The compensation package is also a positive sign of the company's commitment to attracting top talent.

Positives

• The appointment of Jeff Schwaneke brings significant experience in finance and managed care to agilon health.
• His previous role at Centene included overseeing a $35 billion pharmacy business and driving substantial revenue growth.
• Mr. Schwaneke's experience as a board member provides him with a deep understanding of agilon's operations and strategy.
• The compensation package is designed to attract and retain a high-caliber executive.

Negatives

• The departure of Timothy Bensley, the previous CFO, may create a transition period for the company.
• Mr. Schwaneke's resignation from the board of directors will require the company to fill that position.

Risks

• The transition to a new CFO could pose operational risks if not managed effectively.
• The company's future performance is subject to risks and uncertainties as detailed in their SEC filings.
• The performance-based stock units are subject to a +100% share price appreciation hurdle, which may not be achieved.

Future Outlook

The company anticipates continued growth and demand for its model among physician practices and payors, and expects Mr. Schwaneke to play a key role in this growth.

Management Comments

• Ron Williams, board chairman, expressed delight in supporting Jeff Schwaneke's appointment as CFO.
• Steve Sell, CEO, stated that demand for agilon's model has never been stronger and welcomed Jeff as CFO.
• Steve Sell thanked Tim Bensley for his contributions over the past three years.
• Jeff Schwaneke expressed excitement to join the Executive Leadership team and meet the growing demand for agilon's model.

Industry Context

The appointment of a seasoned executive like Jeff Schwaneke, with extensive experience in managed care, reflects the industry's focus on value-based care models and the increasing importance of financial expertise in healthcare organizations.

Comparison to Industry Standards

• The compensation package for Mr. Schwaneke, including a base salary, bonus, and equity awards, is consistent with industry standards for CFOs at publicly traded healthcare companies.
• Centene Corporation, where Mr. Schwaneke previously served, is a major player in the managed care sector, and his experience there is directly relevant to agilon's business model.
• The transition from a retiring CFO to a new one is a common occurrence in the industry, and agilon's approach of having the previous CFO stay on for a transition period is a standard practice.
• The use of performance-based stock units (PSUs) with a share price appreciation hurdle is a common incentive mechanism in executive compensation packages.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of an experienced CFO positively.
• Employees may be impacted by the change in leadership.
• The appointment could strengthen the company's relationships with physician partners and payors.

Next Steps

• Mr. Schwaneke will assume his role as CFO on July 1, 2024.
• The company will file the Employment Agreement and Offer Letter as exhibits to its Quarterly Report on Form 10-Q for the period ending June 30, 2024.

Key Dates

Keywords

Chief Financial Officer, CFO, agilon health, Jeff Schwaneke, executive appointment, managed care, finance, compensation, equity awards, Centene Corporation